Radical prostatectomy (RP) remains the preferred treatment option for men with localised prostate cancer (PCa). Following the introduction in 1995, approximately 1,100 procedures are performed annually in Denmark. Several studies have demonstrated the Danish standard of RP to be at an international level in terms of both functional and oncological outcomes. In order to reduce the risk of overtreatment, management of localised PCa should be organised in experienced multidisciplinary teams, where a constantly growing armamentarium of diagnostic and therapeutic options can be offered.